The U.S. ophthalmic drugs market size was estimated at USD 15.53 billion in 2023 and is anticipated to grow at a CAGR of 7.4% from 2024 to 2030. The steady growth in the aging population in the country, coupled with an increasing prevalence of eye-related disorders among adults and children, is expected to remain a significant contributing factor to the demand for ophthalmic...